Literature DB >> 12584429

Are MRI white matter lesions clinically significant in the 'old-old'? Evidence from the Sydney Older Persons Study.

Olivier Piguet1, Lloyd Ridley, David A Grayson, Hayley P Bennett, Helen Creasey, Tanya C Lye, G Anthony Broe.   

Abstract

BACKGROUND: The number of individuals aged over 80 years is the fastest increasing group in developed countries. White matter lesions (WML) observed on magnetic resonance imaging (MRI) have uncertain clinical significance, particularly in the old.
OBJECTIVES: To determine the prevalence of periventricular and deep WML in survivors of an original cohort of randomly selected elderly community dwellers, and to examine their associations with clinical markers of vascular and extrapyramidal disorders of ageing, as well as quantitative cognitive measures.
METHODS: Brain MRI, lifestyle interview, cognitive testing and medical examination were administered to 122 participants from the Sydney Older Persons Study 6-year review (mean age: 85.5 years). Apolipoprotein E (ApoE) genotype was also established. Presence and severity of periventricular and deep WML were ascertained using semi-quantitative rating methods and their relations to the cognitive and clinical variables investigated.
RESULTS: Periventricular WML were present in all participants in similar severity for all three regions sampled. In contrast, a gradient of severity was observed for the deep WML: most severe in the parietal region, followed by the frontal and occipital regions, and least severe in the temporal region. Associations with gender or with the ApoE epsilon4 allele were non-significant. WML were inconsistently associated with age and cognitive functioning or with the clinical markers of dementia. No frontal specificity emerged. Examination of individual lesion types did not change the general pattern of associations. Supporting evidence for a threshold effect was observed on some measures.
CONCLUSIONS: WML are extremely common in elderly, non-demented individuals. Unlike in younger individuals, MRI abnormalities may not be evidence of a current pathological process and their importance may change with advancing age. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12584429     DOI: 10.1159/000068482

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  7 in total

Review 1.  Age-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline.

Authors:  Steven G Kohama; Douglas L Rosene; Larry S Sherman
Journal:  Age (Dordr)       Date:  2011-12-28

2.  In vivo vascular hallmarks of diffuse leukoaraiosis.

Authors:  Jinsoo Uh; Uma Yezhuvath; Yamei Cheng; Hanzhang Lu
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

Review 3.  Poststroke dementia in the elderly.

Authors:  Marie-Anne Mackowiak-Cordoliani; Stéphanie Bombois; Armelle Memin; Hilde Hénon; Florence Pasquier
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Dementia in the oldest old.

Authors:  Zixuan Yang; Melissa J Slavin; Perminder S Sachdev
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

5.  Hippocampal size and memory function in the ninth and tenth decades of life: the Sydney Older Persons Study.

Authors:  T C Lye; O Piguet; D A Grayson; H Creasey; L J Ridley; H P Bennett; G A Broe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

Review 6.  Neuroimaging in the Oldest-Old: A Review of the Literature.

Authors:  Davis C Woodworth; Kiana A Scambray; María M Corrada; Claudia H Kawas; S Ahmad Sajjadi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

7.  Age-dependent association of white matter abnormality with cognition after TIA or minor stroke.

Authors:  Giovanna Zamboni; Ludovica Griffanti; Sara Mazzucco; Sarah T Pendlebury; Peter M Rothwell
Journal:  Neurology       Date:  2019-06-14       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.